2-三甲基甲硅烷基乙基丁-2-炔酸酯 | 851590-91-5

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 中文名称: 2-三甲基甲硅烷基乙基丁-2-炔酸酯
• 英文名称: (2-trimethylsilyl)ethyl but-2-ynoate
• 英文别名: 2-(trimethylsilyl)ethyl but-2-ynoate；2-Butynoic acid, 2-(trimethylsilyl)ethyl ester；2-trimethylsilylethyl but-2-ynoate
• CAS: 851590-91-5
• 化学式: C₉H₁₆O₂Si
• 分子量: 184.31
• InChiKey: CBYQMALISYAPIN-UHFFFAOYSA-N

物化性质

• 沸点：
  234.5±23.0 °C(Predicted)
• 密度：
  0.923±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.89
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-三甲基甲硅烷基乙基丁-2-炔酸酯 在 bis-triphenylphosphine-palladium(II) chloride copper(I) bromide dimethylsulfide complex 、 三正丁基氢锡 、 lithium diisopropyl amide 作用下， 以 四氢呋喃 为溶剂， 反应 65.25h， 生成 2-(trimethylsilyl)ethyl (2E,4E,6S,7S,8R,9S,10E)-7,9-dimethoxy-3,6,8-trimethyl-11-phenylundeca-2,4,10-trienoate
  参考文献：
  名称：

  Formal Total Syntheses of Crocacin A-D

  摘要：

  本文介绍了一种简明的方法，用于合成蝎子碱A-D（1-4）中的常见多酮片段5，该方法之前已被多种方式转化为这种真菌杀菌和细胞毒素家族的所有成员。我们的合成特点是使用了一种由缬氨醇衍生的辅助剂控制的钛醛反应，并且采用了锌介导的、钯催化的反式选择性丙炔基甲烷磺酸酯10加到手性醛9上的方法，同时比较了钯催化的Stille和Suzuki交叉偶联反应来形成目标化合物的二烯基基团。

  DOI：

  10.1135/cccc20051696
• 作为产物：
  描述：

  2-(三甲硅基)乙醇 、 2-丁炔酸 在 4-二甲氨基吡啶 、 N,N'-二环己基碳二亚胺 作用下， 以 二氯甲烷 为溶剂， 生成 2-三甲基甲硅烷基乙基丁-2-炔酸酯
  参考文献：
  名称：

  Approaches to the quaternary stereocentre and to the heterocyclic core in diazonamide A using the Heck reaction and related coupling reactions

  摘要：

  在对二氮酰胺A（早期结构2；修订后的结构1）中四次碳中心进行的模型研究中，显示在Heck反应条件下，碱基取代的碘芳烃4、13、18和23的环化反应分别生成了相应的苯并二氢呋喃5、苯并噁唑酮14以及氧吲哚19和24，得率为50-80%。进一步操作苯并二氢呋喃5后，得到了中间体30、33和39，它们构成了二氮酰胺A中噁唑–吲哚杂环核心的一部分。从前体46a（由44和45制备而成）进行相应的13-exo-trig Heck环化反应以生成47的尝试未能成功。在试图从酯57和相关醚59进行Heck环化时也得到了类似的结果。用Pd(OAc)2、PPh3和Ag2CO3处理含克罗门的碘芳烃62，生成了结晶固体螺环64。X射线晶体结构分析确定64中的四次碳中心的构型与二氮酰胺A（1）中的构型相同。

  DOI：

  10.1039/b609604b

文献信息

• DI - SUBSTITUTED PYRIDINE DERIVATIVES AS ANTICANCERS
  申请人：Takasu Hideki

  公开号：US20120283242A1

  公开（公告）日：2012-11-08

  The present invention provides a novel compound having an excellent antitumor effect. The compound of the present invention is represented by the following general formula (1) wherein R 1 and R 2 are aryl or the like; A is lower alkylene; Ring X is optionally substituted arylene; E is bond or lower alkenylene; Ring Y is optionally substituted heterocycloalkylene containing one or more nitrogen atoms, one of which is attached to the adjacent carbonyl group; G is —NH-G 2 -, —N(lower alkyl)-G 2 -, —NH—CH 2 -G 2 -, —N(lower alkyl)-CH 2 -G 2 - or —CH 2 -G 2 -, [wherein G 2 binds to R 2 , G 2 -R 2 is bond-R 2 , phenylene-G 3 -R 2 , phenylene-G 4 -O—R 2 , phenylene-G 5 -NH—R 2 , phenylene-G 6 -N(lower alkyl)-R 2 or quinolinediyl-O—R 2 , the phenylene of said phenylene-containing groups being optionally substituted with one or more substituents; G 3 -R 2 is —O-lower alkylene-R 2 or the like; G 4 -O— is lower alkylene-O— or the like; G 5 is lower alkylene; G 6 is lower alkylene].

  本发明提供了一种具有优异抗肿瘤效果的新型化合物。本发明的化合物由下述通式（1）表示，其中R1和R2为芳基或类似物；A为低级烷基；环X为可选取代的芳基；E为键或低级烯基；环Y为可选取代的杂环烷基，其中一个氮原子连接到相邻的羰基；G为—NH-G2-，—N(低级烷基)-G2-，—NH—CH2-G2-，—N(低级烷基)-CH2-G2-或—CH2-G2-，[其中G2与R2相连，G2-R2为键-R2，苯基-G3-R2，苯基-G4-O—R2，苯基-G5-NH—R2，苯基-G6-N(低级烷基)-R2或喹啉基-O—R2，所述苯基含有的苯基-含基团可选取代一个或多个取代基；G3-R2为—O-低级烷基-R2或类似物；G4-O—为低级烷基-O—或类似物；G5为低级烷基；G6为低级烷基]。
• Di-substituted pyridine derivatives as anticancers
  申请人：Takasu Hideki

  公开号：US08722663B2

  公开（公告）日：2014-05-13

  The present invention provides a novel compound having an excellent antitumor effect. The compound of the present invention is represented by the following general formula (1) wherein R1 and R2 are aryl or the like; A is lower alkylene; Ring X is optionally substituted arylene; E is bond or lower alkenylene; Ring Y is optionally substituted heterocycloalkylene containing one or more nitrogen atoms, one of which is attached to the adjacent carbonyl group; G is —NH-G2-, —N(lower alkyl)-G2-, —NH—CH2-G2-, —N(lower alkyl)-CH2-G2- or —CH2-G2-, [wherein G2 binds to R2, G2-R2 is bond-R2, phenylene-G3-R2, phenylene-G4-O—R2, phenylene-G5-NH—R2, phenylene-G6-N(lower alkyl)-R2 or quinolinediyl-O—R2, the phenylene of said phenylene-containing groups being optionally substituted with one or more substituents; G3-R2 is —O-lower alkylene-R2 or the like; G4-O— is lower alkylene-O— or the like; G5 is lower alkylene; G6 is lower alkylene].

  本发明提供了一种具有优异抗肿瘤效果的新化合物。本发明的化合物由以下一般式（1）表示，其中R1和R2是芳基或类似物; A是低碳链烷基; 环X是可选取代的芳基; E是键或低碳链烯烃基; 环Y是可选取代的杂环烷基，其中含有一个或多个氮原子，其中一个与相邻的羰基团结合; G是—NH-G2-, —N（低碳基）-G2-, —NH—CH2-G2-, —N（低碳基）-CH2-G2-或—CH2-G2-, [其中G2与R2结合，G2-R2是键-R2，苯基-G3-R2，苯基-G4-O—R2，苯基-G5-NH—R2，苯基-G6-N（低碳基）-R2或喹啉基-O—R2，所述苯基含基团可选地取代; G3-R2是—O-低碳链烷基-R2或类似物; G4-O—是低碳链烷基-O—或类似物; G5是低碳链烷基; G6是低碳链烷基]。
• Phosphine-catalyzed regioselective heteroaromatization between activated alkynes and isocyanides leading to pyrroles
  作者：Shin Kamijo、Chikashi Kanazawa、Yoshinori Yamamoto

  DOI：10.1016/j.tetlet.2005.02.104

  日期：2005.4

  The organophosphine catalyzed reaction of activated alkynes with isocyanides produces the corresponding heteroaromatization products, pyrroles, regioselectively in good yields. The reaction proceeds most probably through the 1,4-addition of the nucleophilic phosphine catalyst to the alkynes, followed by a [3+2] cycloaddition between the resulting alkenyl phosphine intermediates and a carbanion derived from the isocyanides. (c) 2005 Elsevier Ltd. All rights reserved.
• Approaches to the quaternary stereocentre and to the heterocyclic core in diazonamide A using the Heck reaction and related coupling reactions
  作者：James E. M. Booker、Alicia Boto、Gwydion H. Churchill、Clive P. Green、Matthew Ling、Graham Meek、Jaya Prabhakaran、David Sinclair、Alexander J. Blake、Gerald Pattenden

  DOI：10.1039/b609604b

  日期：——

  In model studies towards the quaternary centre at the heart of diazonamide A (early structure 2; revised structure 1), cyclisations of the alkene-substituted iodoaryls 4, 13, 18 and 23, under Heck reaction conditions, were shown to lead to the corresponding benzodihydrofuran 5, benzofuranone 14 and the oxindoles 19 and 24 respectively, in 50–80% yield. Further manipulation of the benzodihydrofuran 5 then led to the intermediates 30, 33 and 39, which make up parts of the oxazole–indole heterocyclic core in diazonamide A. Attempts to perform a corresponding 13-exo-trig Heck cyclisation from the precursor 46a, prepared from 44 and 45, leading to 47 were not successful. A similar outcome was obtained during attempts to effect Heck cyclisations from the ester 57 and the related ether 59. Treatment of the chromene-substituted iodoaryl 62 with Pd(OAc)2, PPh3 and Ag2CO3 led to the spirocycle 64 as a crystalline solid. X-Ray crystal structure analysis established that the quaternary centre in 64 had the same configuration as that present in diazonamide A (1).

  在对二氮酰胺A（早期结构2；修订后的结构1）中四次碳中心进行的模型研究中，显示在Heck反应条件下，碱基取代的碘芳烃4、13、18和23的环化反应分别生成了相应的苯并二氢呋喃5、苯并噁唑酮14以及氧吲哚19和24，得率为50-80%。进一步操作苯并二氢呋喃5后，得到了中间体30、33和39，它们构成了二氮酰胺A中噁唑–吲哚杂环核心的一部分。从前体46a（由44和45制备而成）进行相应的13-exo-trig Heck环化反应以生成47的尝试未能成功。在试图从酯57和相关醚59进行Heck环化时也得到了类似的结果。用Pd(OAc)2、PPh3和Ag2CO3处理含克罗门的碘芳烃62，生成了结晶固体螺环64。X射线晶体结构分析确定64中的四次碳中心的构型与二氮酰胺A（1）中的构型相同。
• Formal Total Syntheses of Crocacin A-D
  作者：Magnus Besev、Christof Brehm、Alois Fürstner

  DOI：10.1135/cccc20051696

  日期：——

  A concise route to the common polyketide fragment5of crocacin A-D (1-4) is presented which has previously been converted into all members of this fungicidal and cytotoxic family of dipeptidic natural products by various means. Our synthesis features asyn-selective titanium aldol reaction controlled by a valinol-derived auxiliary, a zinc-mediated, palladium-catalyzedanti-selective addition of propargyl mesylate10to the chiral aldehyde9, as well as a comparison of palladium-catalyzed Stille and Suzuki cross-coupling reactions for the formation of the diene moiety of the target.

  本文介绍了一种简明的方法，用于合成蝎子碱A-D（1-4）中的常见多酮片段5，该方法之前已被多种方式转化为这种真菌杀菌和细胞毒素家族的所有成员。我们的合成特点是使用了一种由缬氨醇衍生的辅助剂控制的钛醛反应，并且采用了锌介导的、钯催化的反式选择性丙炔基甲烷磺酸酯10加到手性醛9上的方法，同时比较了钯催化的Stille和Suzuki交叉偶联反应来形成目标化合物的二烯基基团。